Joshua Hare Buys 106,383 Shares of Longeveron Inc. (NASDAQ:LGVN) Stock

Longeveron Inc. (NASDAQ:LGVN) insider Joshua Hare purchased 106,383 shares of the firm’s stock in a transaction that occurred on Wednesday, April 10th. The shares were acquired at an average cost of $2.35 per share, for a total transaction of $250,000.05. Following the purchase, the insider now owns 590,727 shares of the company’s stock, valued at $1,388,208.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Longeveron Trading Down 16.3 %

Shares of LGVN opened at $1.69 on Monday. Longeveron Inc. has a twelve month low of $1.62 and a twelve month high of $44.00. The company has a market cap of $4.24 million, a P/E ratio of -0.17 and a beta of 0.21. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.21. The company’s fifty day simple moving average is $4.32 and its 200-day simple moving average is $12.27.

Longeveron (NASDAQ:LGVN) last announced its earnings results on Tuesday, February 27th. The company reported ($2.50) earnings per share for the quarter, missing the consensus estimate of ($2.10) by ($0.40). Longeveron had a negative net margin of 3,020.17% and a negative return on equity of 209.14%. The firm had revenue of $0.06 million during the quarter, compared to analysts’ expectations of $0.21 million. As a group, analysts expect that Longeveron Inc. will post -8.5 EPS for the current year.

Institutional Investors Weigh In On Longeveron

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Armistice Capital LLC purchased a new stake in shares of Longeveron in the fourth quarter valued at $2,497,000. Vanguard Group Inc. grew its holdings in shares of Longeveron by 6.1% in the third quarter. Vanguard Group Inc. now owns 184,267 shares of the company’s stock worth $682,000 after purchasing an additional 10,600 shares during the last quarter. Boothbay Fund Management LLC bought a new position in shares of Longeveron in the second quarter worth about $254,000. Citigroup Inc. bought a new position in shares of Longeveron in the first quarter worth about $1,004,000. Finally, Geode Capital Management LLC grew its holdings in shares of Longeveron by 78.6% in the second quarter. Geode Capital Management LLC now owns 66,392 shares of the company’s stock worth $224,000 after purchasing an additional 29,212 shares during the last quarter. Hedge funds and other institutional investors own 10.01% of the company’s stock.

About Longeveron

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors.